Randal W. Scott
Director at BridgeBio Pharma, Inc. (BBIO)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 19SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 6,20015,389 held (−29%) | $66.69 | $413K | -2.0% |
| May 19SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 2,08813,301 held (−14%) | $67.53 | $141K | -3.2% |
| May 19SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 1,51211,789 held (−11%) | $68.23 | $103K | -4.2% |
| May 19SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 20011,589 held (−2%) | $69.12 | $14K | -5.5% |
| Feb 18SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 1,90019,689 held (−9%) | $74.34 | $141K | -12.1% |
| Feb 18SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 4,79314,896 held (−24%) | $75.57 | $362K | -13.5% |
| Feb 18SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 3,30711,589 held (−22%) | $75.93 | $251K | -13.9% |
| Nov 19SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 3,80117,788 held (−18%) | $66.25 | $252K | -1.4% |
| Nov 19SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 6,19911,589 held (−35%) | $66.89 | $415K | -2.3% |
- Sell
Director Randal W. Scott sold $413K of BBIO at $66.69 — cuts the stake by 29%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Randal W. Scott sold $141K of BBIO at $67.53 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Randal W. Scott sold $103K of BBIO at $68.23 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Randal W. Scott sold $14K of BBIO at $69.12 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Randal W. Scott sold $141K of BBIO at $74.34 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Randal W. Scott sold $362K of BBIO at $75.57 — pre-scheduled 10b5-1 plan sale.